Retatrutide is a triple-agonist peptide that activates three hormone receptors simultaneously to regulate appetite, blood sugar, and metabolism, making it one of the most powerful weight management compounds in clinical development. Unlike single or dual agonists, this GLP-3 RT research peptide targets GLP-1, GIP, and glucagon receptors together, a mechanism that has produced weight loss results exceeding 24% of body weight in clinical trials.
If you’ve been following the conversation around metabolic health and its connection to how we look and feel, you’ve …











